Glioma (DBCOND0017181)

Identifiers

Synonyms
Brain Gliomas / Glial Cell Tumors / Brain Glioma / Gliomas / Glial Tumor / Glial Tumors / Glioma of Brain / Glioma (disorder) / Glioma (morphologic abnormality) / Malignant glioma / Glial tumours malignant / Glioma, malignant (morphologic abnormality)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Aminolevulinic acid
A porphyrin precursor used to treat actinic keratosis of the face, scalp, and upper extremities, as well as to visualize a glioma.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03763396
Azoles Targeting Recurrent High Grade Gliomasother0not_yet_recruiting
NCT03779230
Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapsetreatment1 / 2completed
NCT03849430
Longitudinal Analysis of the Health-related Quality of Life in Glioma PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03916757
V-Boost Immunotherapy in Glioblastoma Multiforme Brain CancerNo drug interventionstreatment2unknown_status
NCT03650257
A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96treatment2unknown_status
NCT03460782
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and GliomasNot AvailableNot Availableno_longer_available
NCT03728673
A Study Utilizing Escitalopram in Glioma Patientstreatment2recruiting
NCT03698162
Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain MetastasesdiagnosticNot Availableterminated
NCT03949192
Efficacy of Kangliuwan for Recurrent Grade IV GliomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03102112
Noninvasively Predicting Gene Status of GliomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT04406610
CAR-T Cell Immunotherapy for GD2 Positive Glioma PatientsNo drug interventionstreatment1 / 2withdrawn
NCT03496181
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages FluentlyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03534050
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern RadiotherapyNo drug interventionstreatment2 / 3recruiting
NCT03750890
Visual Study of Molecular Genotype in Glioma EvolutionNo drug interventionsNot AvailableNot Availableunknown_status
NCT03213002
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMtreatment1 / 2recruiting
NCT03834740
A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resectiontreatment0completed
NCT03935685
Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZtreatment2active_not_recruiting
NCT03189420
Glioma Microenvironment an Exploratory StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03739372
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03194906
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumorssupportive_care2completed
NCT03927274
Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Gliomatreatment0terminated
NCT03436433
Seizure Prophylaxis in Patients With Glioma or Brain Metastasistreatment2terminated
NCT03698201
Blood Biomarker Signature in GliomaNo drug interventionsNot AvailableNot Availableterminated
NCT03665545
Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastomatreatment1 / 2active_not_recruiting
NCT03796507
Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitationtreatment0withdrawn
NCT03311542
Expanded Access for Pembrolizumab (MK-3475)Not AvailableNot Availableno_longer_available
NCT03180697
The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant GliomasNo drug interventionsNot AvailableNot Availableunknown_status
NCT02876016
Cerebral Bases Bodily RepresentationsNo drug interventionsbasic_scienceNot Availableunknown_status
NCT05189366
Sophrology Treatment for Patients With Glial Tumours Requiring Speech TherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT04541082
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsNo drug interventionstreatment1recruiting
NCT05139277
Evaluation of the CONVIVO SystemNo drug interventionsdiagnosticNot Availablerecruiting
NCT01655927
Efficacy of Tranexamic Acid in Brain Tumor Resectionstreatment3unknown_status
NCT05804227
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Low-Grade Gliomas in Adultstreatment0recruiting
NCT02332889
Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETstreatment1 / 2terminated
NCT03952598
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR SpectroscopyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03557359
Nivolumab for Recurrent or Progressive IDH Mutant Gliomastreatment2active_not_recruiting
NCT05054400
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MRtreatment0withdrawn
NCT03154996
Chronic Convection Enhanced Delivery of Topotecantreatment1completed
NCT03091270
ZOOMit-fMRI Identifies Motor Functional CortexNo drug interventionsNot AvailableNot Availablerecruiting
NCT01961934
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progressiondiagnostic2 / 3withdrawn
NCT01517776
Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescentstreatment2terminated
NCT01445691
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgerytreatment2withdrawn
NCT01251913
A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research PurposesNo drug interventionsNot AvailableNot Availableterminated
NCT01225003
Advanced MR Techniques in Detection of Tumor Infiltration and Grading in GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT01144247
Cellular Immunotherapy Study for Brain CancerNo drug interventionstreatment1completed
NCT00967577
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumorstreatment1completed
NCT00832598
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System TumorsNo drug interventionstreatmentNot Availablecompleted
NCT00589706
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade GliomasNo drug interventionstreatment2completed
NCT00200161
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastomatreatment2completed
NCT03042416
18F-DOPA PET Imaging: an Evaluation of Biodistribution and SafetyNo drug interventionsdiagnostic3completed
NCT03984240
The Effects of Mild Sedation on Motor Function Networks in Patients With Brian GliomastreatmentNot Availablerecruiting
NCT05595863
Correlation Between SPECT/CT and IDH Mutation in Brain GliomaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05593809
Single Photon Emission Computed Tomography/Computed Tomography With Pentavalent 99mTc Dimercaptosuccinic Acid in Patients With Brain Glioma; Correlation With IDH MutationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05157594
hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial TumorsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNo drug interventionstreatment1terminated
NCT00879437
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Gliomatreatment2completed
NCT02728024
Assessing Psychosocial and Supportive Care Needs in Patients With GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT06563024
18F-FET PET/CT in the Management of GliomaNo drug interventionsdiagnosticNot Availablecompleted
NCT05577416
A Study of AB-218 in Patients With IDH1 Mutated Low Grade Gliomatreatment0recruiting
NCT03295396
ONC201 in Adults With Recurrent H3 K27M-mutant Gliomatreatment2active_not_recruiting
NCT03626896
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) PatientsNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00575796
Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)treatment2unknown_status
NCT05019196
fMRI Study of Functional Reorganization in Glioma PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00028158
Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain CancerNo drug interventionstreatment1 / 2completed
NCT02597335
Non Invasive Detection of IDH1/2 Mutation in GliomasNo drug interventionsdiagnosticNot Availableunknown_status
NCT05635435
Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and SubtypesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00454935
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With EpilepsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00009035
Natural History of Patients With Brain and Spinal Cord TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT03193463
Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsytreatment0withdrawn
NCT04902586
Effect of Radiotherapy Concurrent of TTFields in Patients With GlioblastomaNo drug interventionstreatmentNot Availableunknown_status
NCT01479686
iMRI Guided Resection in Cerebral Glioma SurgeryNo drug interventionstreatment3completed
NCT04521686
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutationstreatment1active_not_recruiting
NCT00122239
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT02273739
Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutationtreatment1 / 2completed
NCT01595139
MicroRNAs in Patients With Neurofibromatosis Type 1No drug interventionsNot AvailableNot Availablecompleted
NCT04407039
Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep LearningNo drug interventionsNot AvailableNot Availableunknown_status
NCT02122822
Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96No drug interventionstreatment1completed
NCT00256425
Cognitive Rehabilitation of Glioma PatientsNo drug interventionstreatment3unknown_status
NCT06344130
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaNo drug interventionstreatment1not_yet_recruiting
NCT05310448
Tumor Treating Fields for the Treatment of Brainstem GliomasNo drug interventionstreatmentNot Availablerecruiting
NCT01986348
Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomastreatment2terminated
NCT00001148
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the TumorNo drug interventionsNot AvailableNot Availablecompleted
NCT00532948
A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomastreatment1completed
NCT03212157
GlucoCEST MRI in OncologyNo drug interventionsbasic_scienceNot Availablecompleted
NCT04205357
Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastomatreatment1completed
NCT05773326
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGGtreatment0recruiting
NCT00338026
A Phase I Study of ECO-4601 in Patients With Advanced Cancertreatment1completed
NCT04424966
Infigratinib in Recurrent High-Grade Glioma Patientstreatment0terminated
NCT06043765
Reducing Cognitive Impairment in Glioma With Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy TrainingNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00795665
Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Gliomatreatment2completed
NCT05392374
Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine GliomasNot AvailableNot Availableno_longer_available
NCT02115074
Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomastreatment1completed
NCT04539574
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System TumorsNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02520882
68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary GliomasNo drug interventionsdiagnostic0unknown_status
NCT05672082
Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.No drug interventionsdiagnosticNot Availablewithdrawn
NCT03134131
Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade GliomasNot AvailableNot Availableno_longer_available
NCT06546631
Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01212731
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00040573
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.treatment1 / 2completed
NCT05045027
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent GliomaNo drug interventionsbasic_science0recruiting
NCT00977327
Comparison of Neuro-navigational Systems for Resection-Control of Brain TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT00350727
Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Gliomatreatment2completed
NCT05937776
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With GliomasNo drug interventionsNot AvailableNot Availablerecruiting
NCT04065776
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade GliomaNo drug interventionstreatmentNot Availablerecruiting
NCT00147160
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescentstreatment2completed
NCT00870129
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02686229
Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade GliomasNo drug interventionsNot AvailableNot Availablerecruiting
NCT03900689
Social Determinants of Health in Glioblastoma PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT00038389
Study of Vioxx and Radiation Therapy for Brainstem Gliomatreatment1terminated
NCT05464992
Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRINo drug interventionsotherNot Availablerecruiting
NCT03423992
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasNo drug interventionstreatment1unknown_status
NCT02433392
Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.No drug interventionstreatment1terminated
NCT01020292
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Gliomatreatment1completed
NCT01229644
Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomastreatment2terminated
NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers.treatment2 / 3recruiting
NCT04217044
Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial IntelligenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT03741244
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma:RCTtreatment2unknown_status
NCT02854644
Study of the Anti-tumoral Immune ResponseNo drug interventionsbasic_scienceNot Availablecompleted
NCT05990244
Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and AdhesionNo drug interventionsdiagnosticNot Availablerecruiting
NCT06472440
Evaluation of the Use of a Method "Radiomics" for DOPA PET in GliomasNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04752267
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastasesdiagnostic0completed
NCT03718767
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotypetreatment2recruiting
NCT02771301
Safety and Efficacy of IDH1R132H-DC Vaccine in GliomasNo drug interventionstreatmentNot Availableunknown_status
NCT01137604
A Study in Subjects With Recurrent Malignant Gliomatreatment2completed
NCT05958472
Navigating the Clinical Research Process for GliomaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04953468
Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma InvasionNo drug interventionsNot AvailableNot Availableunknown_status
NCT05025969
Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain TumoursNo drug interventionsNot AvailableNot Availablecompleted
NCT04687969
Multimodal Machine Learning Characterization of Solid TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00108069
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumorstreatment2completed
NCT05039346
Quality of Life and Patient Needs in Advanced High Grade GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT02444546
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumorstreatment1completed
NCT00526812
A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomastreatment1completed
NCT03971812
Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade AstrocytomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02987010
Phase 2 Study of IDH305 in Low Grade GliomasNo drug interventionstreatment2withdrawn
NCT06368310
FIH Clinical Investigation of Graphene Electrodes for Brain MappingNo drug interventionsdevice_feasibilityNot Availablenot_yet_recruiting
NCT04056910
Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumorstreatment2completed
NCT00979810
Image-Guided Stereotactic Biopsy of High Grade GliomasdiagnosticNot Availablecompleted
NCT03407781
IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade GliomaNo drug interventionsdiagnostic1completed
NCT03181581
Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain Tissue.No drug interventionsdiagnostic2terminated
NCT05373381
The KetoGlioma (Ketogenic Glioma) StudyNo drug interventionsotherNot Availablewithdrawn
NCT04391595
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patientstreatment0recruiting
NCT02783495
Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor PatientsNo drug interventionstreatmentNot Availableterminated
NCT03843814
Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing GliomaNo drug interventionsdiagnosticNot Availableterminated
NCT00409214
Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litxâ„¢ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Gliomatreatment2completed
NCT02717455
Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Gliomatreatment1completed
NCT03323450
Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working MemoryNo drug interventionssupportive_careNot Availablecompleted
NCT01743950
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumabtreatment2active_not_recruiting
NCT05555550
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGGdiagnostic0not_yet_recruiting
NCT05486923
Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT01081223
Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV GliomaNo drug interventionstreatment1 / 2completed
NCT01166308
Carbon Ion Radiotherapy for Recurrent GliomasNo drug interventionstreatmentNot Availablecompleted
NCT02502708
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumorstreatment1completed
NCT05188508
Pembrolizumab, Olaparib, and Temozolomide for People With Gliomatreatment2recruiting
NCT02119338
5-ALA in Recurrent GliomadiagnosticNot Availableunknown_status
NCT02924038
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)treatment1terminated
NCT00031538
Genetic Analysis of Brain TumorsNo drug interventionsNot AvailableNot Availableterminated
NCT05592743
Vorasidenib Expanded Access ProgramNot AvailableNot Availableavailable
NCT06099743
ASCENT Intervention for Brain Tumor PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00463203
Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapytreatment2completed
NCT01641003
Isolation and Characterization of Cancer Stem Cells Using iFP TechniqueNo drug interventionsNot AvailableNot Availableunknown_status
NCT06116903
Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor ExosomesNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT00107003
GW572016 to Treat Recurrent Malignant Brain Tumorstreatment2completed
NCT03102203
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT05976490
NeuroPathways Intervention for Brain Tumor PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT05979064
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)No drug interventionstreatmentNot Availablerecruiting
NCT02795364
Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma GliomasNo drug interventionstreatmentNot Availableunknown_status
NCT04689321
Revision of the EORTC QLQ-BN20 QuestionnaireNo drug interventionsNot AvailableNot Availableunknown_status
NCT04122521
Radiogenomic and Prognosis Analysis in GliomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00660621
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Gliomatreatment2unknown_status
NCT01263821
Image Guided Therapy in the Treatment of GliomasNo drug interventionsdiagnosticNot Availableterminated
NCT02941302
Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application StudyNo drug interventionstreatmentNot Availableunknown_status
NCT05345002
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Gliomatreatment2recruiting
NCT02658279
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator PhenotypetreatmentNot Availableactive_not_recruiting
NCT06387979
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology BiopsiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06575452
Using the Chemical Modifications Present on RNA Molecules to Diagnose and Treat Brain CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT03796273
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastasestreatment0terminated
NCT06572592
The Predictive Value of MRI for Adult-type Diffuse GliomasNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01204684
Dendritic Cell Vaccine for Patients With Brain Tumorstreatment2completed
NCT03152318
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2treatment1recruiting
NCT05511324
Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT06161519
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsNo drug interventionstreatment1 / 2recruiting
NCT01772771
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramNo drug interventionsNot AvailableNot Availablerecruiting
NCT04186832
Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation TherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT06413706
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapytreatment2not_yet_recruiting
NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)screening2active_not_recruiting
NCT03514069
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastomatreatment1active_not_recruiting
NCT06011109
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumabtreatment1 / 2recruiting
NCT02162732
Molecular-Guided Therapy for Childhood CancerNo drug interventionstreatmentNot Availablecompleted
NCT02372409
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumorstreatment2terminated
NCT03532295
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomastreatment2active_not_recruiting
NCT04617002
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline GliomasNot AvailableNot Availableavailable
NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.treatment1recruiting
NCT05580562
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)treatment3recruiting
NCT05916313
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3No drug interventionstreatment1recruiting
NCT02073994
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutationtreatment1completed
NCT02781792
Temozolomide Chronotherapy for High Grade Gliomatreatment2completed
NCT05413304
Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysistreatment1recruiting
NCT02481154
Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutationtreatment1completed
NCT03343197
Study of AG-120 and AG-881 in Subjects With Low Grade Gliomatreatment1active_not_recruiting
NCT04772456
Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating GliomasNo drug interventionsdiagnostic1recruiting
NCT05460507
Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatmenttreatment1not_yet_recruiting
NCT06512298
Plasticizer Exposure and Its Consequences on HealthNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03991832
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumorstreatment2recruiting
NCT05576103
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06326411
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsNo drug interventionstreatment1recruiting
NCT06355908
IL13Rα2 CAR-T for Patients With r/r GliomaNo drug interventionstreatment1recruiting
NCT06397560
PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06496971
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patientstreatment3not_yet_recruiting
NCT01906385
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)treatment1 / 2recruiting
NCT03095248
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumorstreatment2suspended
NCT03868943
Solriamfetol in Improving Sleep in Patients With Grade II-IV Gliomasupportive_care2suspended
NCT03975959
Memory Perception Assessment in Central/Non-central Nervous System CancersNo drug interventionssupportive_careNot Availablerecruiting
NCT06454097
Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in GliomasNo drug interventionsdiagnosticNot Availablerecruiting
NCT04373720
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated GliomasNo drug interventionsdiagnosticNot Availablerecruiting
NCT05538130
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumorstreatment1recruiting
NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumorstreatment1completed
NCT06412952
68Ga-NOTA-RM26 PET/CT in Glioma PatientsNo drug interventionsdiagnostic0recruiting
NCT06417372
Intraoperative Fluorescent Staining Combined With Microsurgery for GliomasNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04181684
LITT Followed by Hypofractionated RT for Recurrent GliomasNo drug interventionstreatmentNot Availablerecruiting
NCT05383872
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT05727605
Neurocognition After Radiotherapy in CNS- and Skull-base TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT06408428
Glioma Intraoperative MicroElectroCorticoGraphyNo drug interventionsdevice_feasibilityNot Availablenot_yet_recruiting
NCT03964909
Resting-State Functional MRI in Glioma Patients Before and After SurgeryNo drug interventionsdiagnosticNot Availablerecruiting
NCT05968053
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)No drug interventionsNot AvailableNot Availablerecruiting
NCT06381726
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of LifeNo drug interventionstreatmentNot Availablerecruiting
NCT02386241
Identification of Genomic Changes in Families Having Multiple Members With TumorsNo drug interventionsNot AvailableNot Availableterminated
NCT02481349
Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their PartnersNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04943913
Study on TIL for the Treatment of Brain GliomaNo drug interventionstreatment0recruiting
NCT06368934
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant GlioblastomaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04745156
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNo drug interventionsdevice_feasibilityNot Availablenot_yet_recruiting
NCT06363162
Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During SurgeryNo drug interventionsdiagnosticNot Availablerecruiting
NCT03739411
Hyperpolarized Imaging in Diagnosing Participants With GliomaNo drug interventionsdiagnostic1recruiting
NCT06036381
Spatial and Temporal Characterization of Gliomas Using Radiomic AnalysisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06348693
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related AggressivenessNo drug interventionsNot AvailableNot Availablerecruiting
NCT02052648
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumorstreatment1 / 2completed
NCT04309552
Tumor Hypoxia and Proliferation in Patients With High-Grade Gliomadiagnostic1recruiting
NCT04556929
Enhanced Detection in Glioma ExcisionNo drug interventionsdiagnosticNot Availableterminated
NCT05182905
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma PatientsNo drug interventionstreatment0recruiting
NCT06327048
Application of Cognitive Training Based on Remind Strategy in Glioma Patients With Cognitive ImpairmentNo drug interventionsotherNot Availablerecruiting
NCT06330337
Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Gliomatreatment3recruiting
NCT06329570
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)treatment1 / 2not_yet_recruiting
NCT03030066
Study of DS-1001b in Patients With Gene IDH1-Mutated GliomasNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT03180502
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Gliomasupportive_care2active_not_recruiting
NCT03935269
Cereset for CaregiversNo drug interventionssupportive_careNot Availablewithdrawn
NCT05500391
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringNo drug interventionshealth_services_research2recruiting
NCT03048084
Seizure Treatment in Gliomatreatment4recruiting
NCT01638533
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunctiontreatment1active_not_recruiting
NCT03551249
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) DisruptionNo drug interventionstreatmentNot Availablecompleted
NCT04667715
Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating GliomaNo drug interventionstreatmentNot Availablesuspended
NCT04699773
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)No drug interventionstreatmentNot Availablerecruiting
NCT06234319
CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain GliomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT06294418
FCI in Post-operative Low Grade GliomasNo drug interventionsbasic_scienceNot Availablerecruiting
NCT02960230
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomastreatment1 / 2completed
NCT05076513
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Gliomatreatment0recruiting
NCT05604365
FearLess in Cognitively Intact Patients With GliomaNo drug interventionssupportive_careNot Availablecompleted
NCT06241391
Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01661400
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumorstreatment1completed
NCT04975139
Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State NetworksNo drug interventionsNot AvailableNot Availablerecruiting
NCT03684109
Non-invasive Glioma Characterization Through Molecular ImagingNo drug interventionsdiagnosticNot Availablerecruiting
NCT03687957
rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomidetreatment1 / 2recruiting
NCT04543201
Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade GliomaNo drug interventionssupportive_careNot Availablerecruiting
NCT06199388
Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A Retrospective Study Using the SEER Database and Chinese DataNo drug interventionsNot AvailableNot Availablecompleted
NCT03500991
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsNo drug interventionstreatment1active_not_recruiting
NCT04185038
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsNo drug interventionstreatment1recruiting
NCT05686798
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.No drug interventionstreatment1recruiting
NCT06180434
Short Term Outcomes After PRoton And photoN radiOtherapy for IDH Mutated Grade 2 and 3 GliomasNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05274919
Vascular Signature Mapping of Brain Tumor GenotypesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06156150
The Role of B7-H4 in Tumor VaccineNo drug interventionsNot AvailableNot Availablerecruiting
NCT04274283
Tessa Jowell BRAIN MATRIX - Platform StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01502280
Fluorescence-guided Surgery for Low- and High-grade Gliomastreatment3completed
NCT02717962
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Settingtreatment2active_not_recruiting
NCT03149575
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMtreatment3terminated
NCT03050736
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expressiontreatment2active_not_recruiting
NCT03027388
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastomabasic_science2completed
NCT03706625
Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed EnvironmentNo drug interventionsNot AvailableNot Availablecompleted
NCT04870580
[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain BiopsyNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT05303519
Safusidenib Phase 2 Study in IDH1 Mutant Gliomatreatment2recruiting
NCT02800486
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAtreatment2recruiting
NCT05352685
Effects of Propofol on Auditory Event-related Potentials and Brain Functional Connectivity in Patients With Supratentorial GliomaotherNot Availablerecruiting
NCT01491893
PVSRIPO for Recurrent Glioblastoma (GBM)treatment1completed
NCT02549833
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Gliomatreatment1active_not_recruiting
NCT02833701
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Gliomatreatment1terminated
NCT03593993
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent GliomasNo drug interventionsNot AvailableNot Availableterminated
NCT03638167
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsNo drug interventionstreatment1active_not_recruiting
NCT04931732
The circTeloDIAG: Liquid Biopsy for Glioma TumorNo drug interventionsNot AvailableNot Availablerecruiting
NCT05489783
Glioma Developmental and HyperActive Ras Tumor (DHART) BoardNo drug interventionsNot AvailableNot Availablerecruiting
NCT05768178
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.treatment2 / 3recruiting
NCT05873946
Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT06043232
MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for GliomasNo drug interventionsNot AvailableNot Availablerecruiting
NCT06055517
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)No drug interventionstreatmentNot Availablerecruiting
NCT06102837
Tumor Vaccines for Solid TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04446416
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientstreatmentNot Availablecompleted
NCT05607407
Methimazole in Patients With Progressive Glioblastomatreatment2recruiting
NCT05964153
Analysis of Circulating DNA in Blood Samples of Glioma-affected PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT06018870
MRI Contrast Clearance Analysis for Glioma Grading and GenotypingNo drug interventionsNot AvailableNot Availablerecruiting
NCT05386043
Registering Genomics and Imaging of Tumors (ReGIT)Not AvailableNot Availablerecruiting
NCT05553041
18F-Fluciclovine PET-MRI in High-grade Gliomadiagnostic0recruiting
NCT04222309
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)No drug interventionstreatment1suspended
NCT05512403
Evaluation of Diagnostic Performances of 18F-FDOPA PET KIneticsNo drug interventionsdiagnostic3recruiting
NCT01682187
A Dose-Escalation Study in Participants With Recurrent Malignant Gliomatreatment1active_not_recruiting
NCT05901844
Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During SurgeryNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT02879682
nTMS for Motor Mapping of Rolandic LesionsNo drug interventionsdiagnostic2 / 3completed
NCT05062772
Brain Tumor Intraoperative Ultrasound DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05875935
Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation With Imaging Data (ECoG)No drug interventionsscreeningNot Availableterminated
NCT05859659
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)No drug interventionsNot AvailableNot Availablerecruiting
NCT05850377
5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade GliomasNot AvailableNot Availablenot_yet_recruiting
NCT05803057
Accelerating Motor Recovering in Patients With SMA Syndrome After Glioma Surgery by Using nrTMSNo drug interventionstreatmentNot Availablerecruiting
NCT04712214
Use of Non-invasive Optical Analysis in NeurosurgeryNo drug interventionsotherNot Availablerecruiting
NCT03865355
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05259605
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationNo drug interventionsNot AvailableNot Availablerecruiting
NCT05788445
High-frequency nrTMS on the Contralateral Broca Mirror Area for Glioma Patients With Early Postoperative AphasiaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03242824
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Gliomatreatment2completed
NCT01792310
A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid TumoursNo drug interventionstreatment1 / 2completed
NCT05739500
MRI-based Computer Aided Diagnosis Software (V1) for GliomaNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04916015
Histomolecular Profiles of Gliomas in Children and Adolescent/Young AdultsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05049148
Platelets Activation in Brain NeoplasmsNo drug interventionsotherNot Availablerecruiting
NCT05707728
Evaluation of Role of Intraoperative Ultrasound in Gross Total Resection of GliomasNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04233788
Metabolic Characterization of Space Occupying Lesions of the BrainNo drug interventionsNot AvailableNot Availablerecruiting
NCT05700071
MRS of Glioma GenomicsNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT03072134
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant GliomaNo drug interventionstreatment1completed
NCT04097535
Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRINo drug interventionsNot AvailableNot Availablecompleted
NCT05672043
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05611645
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrencetreatment2active_not_recruiting
NCT05569434
68Ga-P16-093 PET/CT Imaging in Glioma PatientsNo drug interventionsdiagnostic1 / 2recruiting
NCT05459441
Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastasestreatment0recruiting
NCT05188534
ZOOMit-fMRI Identifies Language Functional CortexNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05143775
Strategic Intervention on Preserving Language Function During Awake CraniotomyNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05143788
Strategic Intervention on Preserving Motor Function During Awake CraniotomyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05140785
Mapping Molecular Markers of Brain Tumour Activity Using MRINo drug interventionsotherNot Availablenot_yet_recruiting
NCT05133154
LIQUID BIOPSY IN Low-grade Glioma PatientsNo drug interventionsotherNot Availablerecruiting
NCT05061251
Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent GliomaNo drug interventionstreatment0withdrawn
NCT05028400
Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During NeurosurgeryNo drug interventionstreatmentNot Availablecompleted
NCT04970615
Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed ModelsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04809597
Does Notch Regulate Glioma Proliferation ?No drug interventionsNot AvailableNot Availablecompleted
NCT04792437
Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing DataNo drug interventionsNot AvailableNot Availablerecruiting
NCT04781764
The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and Visualization of Targeted Molecules of GliomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04738110
Post-operative Imaging in High Grade Glioma: is Management Influenced?No drug interventionsNot AvailableNot Availablerecruiting
NCT04719806
MR Textural Analysis in Low Grade GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT04706338
Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction.No drug interventionstreatmentNot Availablerecruiting
NCT04668508
Anlotinib to Malignant Brainstem Gliomatreatment2recruiting
NCT04550663
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumorstreatment1not_yet_recruiting
NCT04539431
Glioma Brain Tumours - E12513 - SensiScreen GliomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04461002
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04425798
Connectivity Alterations After Levetiracetam ApplicationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04423094
Foci of Tumor Heterogeneity in Diffuse Low-Grade GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT04388033
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.treatment1 / 2recruiting
NCT04220424
Glioma Patients Registry Based on Radiological, Histopathological and Genetic AnalysisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04216537
Survival Significance of Molecular Pathology and Genetic Variation in Brain GliomasNo drug interventionsNot AvailableNot Availablerecruiting
NCT04217018
MR Based Prediction of Molecular Pathology in Glioma Using Artificial IntelligenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT04215224
Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial IntelligenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT04215211
MR Based Survival Prediction of Glioma Patients Using Artificial IntelligenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT04194593
Biomarker-based Algorithm for Diagnosis of GliomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT04114370
Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Gliomaother0completed
NCT04055688
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for GliomasNot AvailableNot Availablecompleted
NCT04051047
Gemcitabine in Newly-Diagnosed Diffuse Midline Gliomabasic_science0withdrawn
NCT04001257
18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading GliomaNo drug interventionsNot AvailableNot Availablecompleted
NCT03990597
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal CordNo drug interventionssupportive_care1withdrawn
NCT03973892
Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03941626
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesNo drug interventionstreatment1 / 2recruiting
NCT03877861
Validation of Readibandâ„¢ Actigraph and Associated Sleep/Wake Classification AlgorithmsNo drug interventionsNot AvailableNot Availablecompleted
NCT03722355
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Gliomatreatment3completed
NCT03716986
Multimodal Imaging of Hypoxia in GliomasNo drug interventionsdiagnosticNot Availableunknown_status
NCT03690570
Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015No drug interventionsNot AvailableNot Availableunknown_status
NCT03641391
Awake Intraoperative Language Mapping and Chinese Probabilistic Map ConstructionNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesNo drug interventionstreatment1 / 2recruiting
NCT03632317
A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomastreatment2withdrawn
NCT03531333
Intraoperative Ultrasound Guided Glioma Surgery; a Randomised, Controlled Trial.No drug interventionstreatmentNot Availableunknown_status
NCT03463733
Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)treatment1unknown_status
NCT03390062
A Study of Apatinib in Recurrent or Recurrent High-grade Gliomatreatment2unknown_status
NCT03352427
Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterationstreatment2terminated
NCT03335280
68Ga-citrate PET/MR Imaging for GliomaNo drug interventionsNot AvailableNot Availableterminated
NCT03322813
ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating GliomaNo drug interventionstreatmentNot Availablesuspended
NCT03257618
Quality of Life and Neurocognitive FunctioningtreatmentNot Availablecompleted
NCT03168919
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in GliomadiagnosticNot Availableterminated
NCT03082846
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical TrialtreatmentNot Availablecompleted
NCT03058198
The Research on 89Zr-ABT806 PET Imaging in High Grade GliomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT03009318
MRS and 11C-methionine PET/CT in the Diagnosis of GliomaNo drug interventionsdiagnosticNot Availablecompleted
NCT02986815
[11C]Acetate PET in Patients With GliomaNo drug interventionsdiagnosticNot Availableterminated
NCT02978261
Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomastreatment1completed
NCT02977689
Trial of IDH305 in IDH1 Mutant Grade II or III GliomaNo drug interventionstreatment2withdrawn
NCT02919865
MR Perfusion Methods in Patients With Suspected Recurrent High Grade GliomasNo drug interventionstreatmentNot Availablecompleted
NCT02919332
Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With GlioblastomaNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02901925
A Microdose Evaluation Study of ABY-029 in Recurrent GliomaNo drug interventionsbasic_science0completed
NCT02805179
A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastomatreatment2completed
NCT02798406
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effectstreatment2completed
NCT02754362
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastomatreatment2withdrawn
NCT02747407
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain TumorsNot AvailableNot Availablecompleted
NCT02743078
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastomatreatment2terminated
NCT02713984
A Clinical Research of CAR T Cells Targeting HER2 Positive CancerNo drug interventionstreatment1 / 2withdrawn
NCT02689336
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumorstreatment2withdrawn
NCT02678975
Disulfiram in Recurrent Glioblastomatreatment2 / 3completed
NCT02676687
Supratotal Resection for Gliomas Within Noneloquent AreasNo drug interventionstreatmentNot Availableunknown_status
NCT02666066
Radiomics for Prediction of Survival in GBMNo drug interventionsNot AvailableNot Availablecompleted
NCT02652897
Hemostasis Alterations in Neurosurgical PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02622620
Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI TechniquesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02520492
Non Invasive Measurements of Intracranial Pressure in Patients With Malignant GliomaNo drug interventionsdiagnosticNot Availablecompleted
NCT02518061
11C-Methionine PET as Prognostic Marker of GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT02507232
Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomastreatment0terminated
NCT02496741
Metformin And Chloroquine in IDH1/2-mutated Solid Tumorstreatment1 / 2completed
NCT02481960
Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade GliomaNo drug interventionstreatment1 / 2terminated
NCT02454634
Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV GliomasNo drug interventionstreatment1completed
NCT02439164
Sedatives' Effects on Neurological Function in Patients With Eloquent Area GliomaotherNot Availablecompleted
NCT02402075
Spinal Motor Evoked Potentials in Brain SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT02387840
Feasibility and Clinically Application of Magnetic Resonance FingerprintingNo drug interventionsdiagnosticNot Availableterminated
NCT02371031
FDOPA-PET/MRI for the Pre-operative Evaluation of GliomasNo drug interventionsdiagnostic1terminated
NCT02363075
Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Astheniatreatment3unknown_status
NCT02345824
Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Gliomatreatment1unknown_status
NCT02327442
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02279992
Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastasestreatment0terminated
NCT02272452
Assistance in Neurosurgery (ExtempoRMN)No drug interventionsNot AvailableNot Availableunknown_status
NCT02253212
Safety of BBB Opening With the SonoCloudtreatment1 / 2completed
NCT02234297
Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing SurgeryNot Available1completed
NCT02176720
Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaNo drug interventionsdiagnostic1terminated
NCT02105233
Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking FluidNo drug interventionsdiagnostic1completed
NCT02099487
Hypofractionated Imrt (Vmat-Ra) For Elderly Patients With Newly Diagnosed High Grade GliomaNo drug interventionstreatment2completed
NCT02082119
Hypofractionated IMRT With Temozolomide for HGGNo drug interventionstreatmentNot Availablecompleted
NCT02029690
Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatintreatment1terminated
NCT02022800
Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)No drug interventionsdiagnosticNot Availablecompleted
NCT02010606
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastomatreatment1completed
NCT01999270
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumorstreatment1completed
NCT01967810
ANG1005 in Patients With Recurrent High-Grade Gliomatreatment2completed
NCT01902771
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain TumorsNo drug interventionstreatment1terminated
NCT01861990
Valproic Acid in Childhood Progressive Brain Tumorstreatment1withdrawn
NCT01836536
Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patientsbasic_scienceNot Availablecompleted
NCT01813877
Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaNo drug interventionsdiagnosticNot Availablecompleted
NCT01811524
The Etiology and Progression of Brain TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT01801852
Autologous Natural Killer T Cells Infusion for the Treatment of CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01801371
68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of GliomaNo drug interventionsdiagnostic0unknown_status
NCT01798771
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT01778088
Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Gliomatreatment2withdrawn
NCT01598454
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosidestreatment1completed
NCT01579253
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01567202
Study of DC Vaccination Against GlioblastomaNo drug interventionstreatment2unknown_status
NCT01525459
Gene Expression, Immunological Status and Metabolome in Glioma PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01502605
Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomasdiagnostic1terminated
NCT01478178
Safety Study of VAL-083 in Patients With Recurrent Malignant Gliomatreatment1 / 2completed
NCT01473485
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain TumorsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01465347
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastomatreatment1 / 2completed
NCT01460706
Imaging Malignant Glioma With 68Ga-DOTATOC PET/CTbasic_science2 / 3completed
NCT01450826
Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomidetreatment2completed
NCT01403311
A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the BrainNo drug interventionstreatment2unknown_status
NCT01394692
Comparative Study of Intraoperative MRI-guided vs. Conventional Glioma SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT01351519
A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumorstreatment2terminated
NCT01331135
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumorstreatment1completed
NCT01220271
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Gliomatreatment1 / 2completed
NCT01182883
A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumorstreatment1withdrawn
NCT01158651
Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomasprevention2completed
NCT01140568
Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomastreatment2completed
NCT01138813
Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)No drug interventionsNot AvailableNot Availablecompleted
NCT01125800
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBtreatment1 / 2completed
NCT01116661
Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the BrainNo drug interventionstreatment2terminated
NCT01044966
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastomatreatment1 / 2terminated
NCT00985036
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00979173
Pharmacokinetics (PK) Study of AC480 for Recurrent Gliomatreatment1completed
NCT00939315
Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/SpectroscopyNo drug interventionsNot AvailableNot Availablecompleted
NCT00909558
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerNo drug interventionstreatment1suspended
NCT00880061
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Gliomatreatment1terminated
NCT00815152
Coping With High Grade GliomaNo drug interventionssupportive_careNot Availableterminated
NCT00813787
Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 ComponentsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00795457
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomastreatment0completed
NCT00782626
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomastreatment2completed
NCT00734864
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant GliomaNo drug interventionstreatment1withdrawn
NCT00727506
BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Gliomatreatment2completed
NCT00723827
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)Not AvailableNot Availablecompleted
NCT00705198
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)Not AvailableNot Availablecompleted
NCT00694330
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent TumorNo drug interventionstreatment1completed
NCT00686387
Establishment of a Brain and Spinal Tumor Tissue BankNo drug interventionsNot AvailableNot Availableunknown_status
NCT00660283
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Gliomatreatment2unknown_status
NCT00424554
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)treatment2completed
NCT00418899
Gliogene: Brain Tumor Linkage StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00412542
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomastreatment2completed
NCT00404495
Combination of Irinotecan and Temozolomide in Children With Brain Tumors.treatment2completed
NCT00392171
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)treatment2completed
NCT00389090
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Gliomatreatment2terminated
NCT00379132
131-I-TM-601 Study in Adults With Solid Tumorstreatment1completed
NCT00360828
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomasdiagnostic2terminated
NCT00352820
Experience of Brain Tumor CaregiversNo drug interventionsNot AvailableNot Availablecompleted
NCT00339352
A Family Study of Adults With GliomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00330109
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging TechnologyNo drug interventionsdiagnosticNot Availableunknown_status
NCT00250211
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and TemozolomideNo drug interventionstreatment1 / 2completed
NCT00214175
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance RadiotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00213278
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Gliomatreatment2completed
NCT00185848
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid ArthritisNo drug interventionsdiagnostic1completed
NCT00165360
Prolonged Daily Temozolomide for Low-Grade Gliomatreatment2completed
NCT00137488
Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)No drug interventionsNot AvailableNot Availablecompleted
NCT00108056
Enzastaurin to Treat Recurrent Brain Tumortreatment1terminated
NCT00080054
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomastreatment1completed
NCT00059020
The Role of Gene Changes in Brain Tumor Formation and GrowthNo drug interventionsNot AvailableNot Availablecompleted
NCT00047879
Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomastreatment2completed
NCT00045968
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancertreatment3active_not_recruiting
NCT00038441
Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomastreatment1 / 2completed
NCT00001502
A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumorstreatment1completed
NCT00001573
A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancytreatment1completed
NCT00001171
Evaluation of Factors in Human Brain TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT06018363
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell InjectionNo drug interventionstreatment1 / 2recruiting